CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Supernus and Indivior merge to create scaled, CNS-focused entity

Positive
AI Analysis

Summary

Supernus Pharmaceuticals and Indivior announced a merger to create a scaled CNS-focused entity combining their commercial medicinal portfolios in CNS and opioid use disorder treatments.

Importance:7/10
Sentiment:
0.50
mergerCNSopioid use disorderportfolio combination
Related Companies

Read the original article

Published by Pharmaceutical Technology on August 4, 2026 10:57 AM

Read Original